Blackrock Clinic in Europe performed the first procedure using the Varipulse™ Pulsed Field Ablation (PFA) platform for atrial fibrillation treatment. The Varipulse™ platform uses electric voltage instead of thermal energy to combat AF, leading to potentially greater efficiency and safety outcomes. The technology has been approved earlier in the year and has shown positive results in clinical trials. Blackrock Clinic’s CEO highlighted the importance of innovating treatment options for AF, a growing health concern. The clinic is renowned for its pioneering heart treatments and procedures, providing a full range of cardiology services. For further information, visit Blackrock Health’s website.
Source link
Blackrock Health first in Europe to use new technology to treat Atrial Fibrillation
